QCL Shift Analyst (Full Rotation) at Eli Lilly and Company

Kinsale, County Cork, Ireland

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • B.Sc. in Analytical Chemistry or other related discipline
  • Strong understanding of safety hazards, basis of safety and risk assessment and an ability to react appropriately
  • Strong technical aptitude and willingness to learn new tasks/technology
  • E-Systems competency and knowledge of Empower
  • Experience with process analytical technologies, HPLC/UPLC and GC an advantage
  • Proven ability to work independently in a fast-paced environment, own tasks and training, problem solve/troubleshoot and adapt to changing priorities
  • Strong collaborative skills with an ability to work effectively in a team environment
  • Excellent communication (written, oral, listening) skills
  • Excellent attention to detail and accuracy in execution
  • Customer focus; takes personal responsibility for speed, quality and accuracy of delivery
  • Self-motivated, positive and ability to work under pressure

Responsibilities

  • Support all aspects of IE2b operations: processing, cleaning, Process Analytical Technology (PAT) and data review
  • Execute online, at-line and offline analytical testing, to support manufacturing
  • Perform analytical techniques in chromatography, including HPLC, Agilent UPLC, Waters PATrol UPLC and GC, spectroscopic methods, and wet chemistry techniques, etc
  • Function as technical resource (Subject Matter Expert) for analytical technologies related to the peptide manufacturing process and train other analysts in this area of expertise as required
  • Respond appropriately to equipment failures (including laboratory and on the floor instrumentation) to minimize process down time, including enacting business continuity procedures
  • Perform primary review and second person verification of process data and results and trend analysis, including process monitoring (PAT review) and fast processing of data
  • Conduct and document laboratory investigations to completion
  • Maintain the laboratory facility, equipment and on the floor process analytical equipment in an inspection-ready state
  • Liaise with other functions (Quality Control, Quality Assurance, Operations, Automation, Technical Services and Facilities, etc.) and contractors, as necessary
  • Communication during handover to other shifts, as to the testing/equipment status and details of any issues/problems that have occurred
  • Actively participate in assigned laboratory and building processes such as, safety audits, procedure revision, housekeeping, and improvement projects

Skills

HPLC
UPLC
GC
Chromatography
Spectroscopy
Wet Chemistry
Process Analytical Technology
Analytical Testing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI